ABT: Abbott Laboratories Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 147,719.29
Enterprise Value ($M) 162,867.81
Book Value ($M) 30,925.00
Book Value / Share 17.50
Price / Book 4.77
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 1.13
Current Ratio 1.58

Balance Sheet (mrq) ($M)
Current Assets 14,409.00
Assets 67,610.00
Liabilities 36,685.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 3,650.00
Net Income 2,368.00
Earnings Per Share Basic 1.34
Earnings Per Share Diluted 1.33

Cash Flow Statement (mra) ($M)
Cash From Operations 6,300.00
Cash from Investing -1,356.00
Cash from Financing -1,356.00

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-02-13 13G Capital Research Global Investors 6.90
2019-02-11 13G/A Vanguard Group Inc 8.21 7.85
2019-02-04 13G/A BlackRock Inc. 6.90 9.84

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-07-31 10-Q ABT / Abbott Laboratories 10-Q – Quarterly Report – FORM 10-Q
2019-05-01 10-Q ABT / Abbott Laboratories 10-Q Quarterly Report 10-Q
2019-02-22 10-K ABT / Abbott Laboratories 10-K (Annual Report)
2018-10-31 10-Q ABT / Abbott Laboratories 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
ABBV – AbbVie Inc. AGN – Allergan plc
ALR – Alere Inc.


Financial data and stock pages provided for FREE by
Fintel.io